The Miami Project to Cure Paralysis
University of Miami School of Medicine
    
 
 
About The Miami Project
Paralysis
Research
Active Studies
  Basic Science
  Clinical Science
  Notable Accomplishments
  Five Steps to a Cure
  Research Reviews
  Directors' Summaries
  Publications
  Frequently Asked Questions
  Schedule of Lectures
Faculty
Lois Pope LIFE Center
The Buoniconti Fund to Cure Paralysis
Women's Guild
Video Archives
 
 
Visitors
Employment/Training
Media

 

 
    
  Facing SCI    Donate    Events Calendar    In The News    Marketplace    Newsletters    Join Mailing List    Contact Us 

2002 Director's Summary Synopsis

DO NEUROPROTECTIVE STRATEGIES PROTECT KEY TISSUES TO PRESERVE FUNCTION?
W. Dalton Dietrich, Ph.D. • Helen M. Bramlett, Ph.D. • Martin Oudega, Ph.D.
John R. Bethea, Ph.D. • Patrick M. Wood, Ph.D. • Mary B. Bunge, Ph.D.

In developing neuroprotective strategies, clarifying changes in the nervous system and identifying the specific tissues that need protection is important to the goal of preserving or restoring function. We also need to understand the immediate and delayed damage following injury. Drs. Bramlett and Dietrich examined the structural changes of the nervous system in brain injured animals one year after injury. They designed this study to help determine the course of progressive tissue loss following chronic central nervous system (CNS) injury. They found that both gray and white matter was affected. White matter damage may be the reason for some long term deficits experienced by patients with CNS injury.

In another study of spinally injured animals, researchers evaluated the effects of two well-known neuroprotective agents. Methylprednisolone (MP) is a drug commonly given to people within hours of their SCI. IL-10 is an anti-inflammatory drug tested in animals and shown to reduce tissue loss at the site of the lesion. Dr. Bunge and her colleagues evaluated the effects of MP and IL-10 administered alone or in combination. They looked at the volume of spared spinal tissue, nerve fiber preservation, and functional recovery. All combinations of the drugs produced similar results in increasing the volume of spared gray matter and preserving the number of axons. None of the treatment strategies, however, resulted in significant improvement in hindlimb function. Clearly, neuroprotective strategies to reduce gray matter damage are important, however, the lack of improvement in function seen in this study points to the importance of also developing treatments to limit white matter damage. This knowledge may lead to the design of new therapies to repair specific tissues that may be essential to recovery of function.

Synopsis Publications

 Bramlett HM, Dietrich WD (2002) Quantitative structural changes in white and gray matter 1 year following traumatic brain injury in rats. Acta Neuropathol 103:607-614.

 Takami T, Oudega M, Bethea JR, Wood PM, Kleitman N, Bunge MB (2002) Methylprednisolone and interleukin-10 reduce gray matter damage in the contused Fischer rat thoracic spinal cord but do not improve functional outcome. J Neurotrauma 2002; May;19(5): 653-66

 
   Copyright ©1997-2007 University of Miami, All Rights Reserved.
   Terms of Use | Privacy Statement | Miami Project Contact Us
Medical Disclaimer   
Web Technology